Carregant...

Bisphosphonate therapy for osteogenesis imperfecta

BACKGROUND: Osteogenesis imperfecta is caused by a genetic defect resulting in an abnormal type I collagen bone matrix which typically results in multiple fractures with little or no trauma. Bisphosphonates are used in an attempt to increase bone mineral density and reduce these fractures in people...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Dwan, Kerry, Phillipi, Carrie A, Steiner, Robert D, Basel, Donald
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2016
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6611487/
https://ncbi.nlm.nih.gov/pubmed/27760454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005088.pub4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!